NCT04983901 2024-11-04
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
M.D. Anderson Cancer Center
Phase 2 Completed
Clinical Trials
4 trialsNCT00261807 2022-01-27
Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections
University of Maryland, Baltimore
Phase NA Completed
NCT00296049 2018-08-10
Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy
Wake Forest University Health Sciences
Phase NA Withdrawn
NCT00335478 2017-05-09
Daptomycin in Treating Neutropenia and Fever in Patients With Cancer
OHSU Knight Cancer Institute
Phase 2 Completed